These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17624855)

  • 41. Clofazimine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):96-9. PubMed ID: 18486040
    [No Abstract]   [Full Text] [Related]  

  • 42. Capreomycin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):89-91. PubMed ID: 18486038
    [No Abstract]   [Full Text] [Related]  

  • 43. Amikacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):87-8. PubMed ID: 18486037
    [No Abstract]   [Full Text] [Related]  

  • 44. Para-aminosalicylic acid.
    Tuberculosis (Edinb); 2008 Mar; 88(2):137-8. PubMed ID: 18486053
    [No Abstract]   [Full Text] [Related]  

  • 45. New drugs for tuberculosis: current status and future prospects.
    O'Brien RJ; Spigelman M
    Clin Chest Med; 2005 Jun; 26(2):327-40, vii. PubMed ID: 15837114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Morphology of healing process during modern therapy of tuberculosis (review)].
    Puzik VI; Zemskova ES
    Probl Tuberk; 1978 Feb; (2):64-9. PubMed ID: 643871
    [No Abstract]   [Full Text] [Related]  

  • 47. Clarithromycin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):92-5. PubMed ID: 18486039
    [No Abstract]   [Full Text] [Related]  

  • 48. OPC-67683.
    Tuberculosis (Edinb); 2008 Mar; 88(2):132-3. PubMed ID: 18486051
    [No Abstract]   [Full Text] [Related]  

  • 49. Linezolid.
    Tuberculosis (Edinb); 2008 Mar; 88(2):122-5. PubMed ID: 18486048
    [No Abstract]   [Full Text] [Related]  

  • 50. SQ109.
    Tuberculosis (Edinb); 2008 Mar; 88(2):159-61. PubMed ID: 18486060
    [No Abstract]   [Full Text] [Related]  

  • 51. Moxifloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
    [No Abstract]   [Full Text] [Related]  

  • 52. The ethics of non-inferiority trials.
    Nunn AJ; Meredith SK; Spigelman MK; Ginsberg AM; Gillespie SH
    Lancet; 2008 Mar; 371(9616):895; author reply 896-7. PubMed ID: 18342678
    [No Abstract]   [Full Text] [Related]  

  • 53. Outcome of extensively drug-resistant tuberculosis.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):794; author reply 794-5. PubMed ID: 19460259
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatitis C and tuberculosis: new hopes].
    Nau JY
    Rev Med Suisse; 2009 May; 5(203):1082. PubMed ID: 19526980
    [No Abstract]   [Full Text] [Related]  

  • 55. Nutrient supplementation and tuberculosis treatment outcome.
    Leung CC; Yew WW
    J Infect Dis; 2009 Jan; 199(2):287-8; author reply 288. PubMed ID: 19115984
    [No Abstract]   [Full Text] [Related]  

  • 56. Biliary obstruction due to isolated pancreatic tuberculosis.
    Koopal SA; Kibbelaar RE; Zijlstra JA; Pierie JP
    JOP; 2005 Nov; 6(6):603-4. PubMed ID: 16286713
    [No Abstract]   [Full Text] [Related]  

  • 57. Approach to tuberculosis of the bone marrow.
    Mehta J; Singhal S; Mehta BC
    J Assoc Physicians India; 1992 Sep; 40(9):639-40. PubMed ID: 1308038
    [No Abstract]   [Full Text] [Related]  

  • 58. Shortening treatment of tuberculosis: lessons from fluoroquinolone trials.
    Nimmo C; Lipman M; Phillips PP; McHugh T; Nunn A; Abubakar I
    Lancet Infect Dis; 2015 Feb; 15(2):141-3. PubMed ID: 25749057
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current modalities for the treatment of tuberculosis].
    Delaude A; Leophonte P; Didier A; Rouquet RM
    Bull Acad Natl Med; 1986 Oct; 170(7):927-37. PubMed ID: 3548901
    [No Abstract]   [Full Text] [Related]  

  • 60. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
    Tang PA; Bentzen SM; Chen EX; Siu LL
    J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.